GB
Selectis Health, Inc.
GBCS · OTC
$5.74 +0.00% (+$0.00)
1M +2.68%
Market Cap $17.6M
P/E Ratio 1.21x
Div. Yield -
ROE -
Bulios Fair Price
$6.19
7.8% upside
Current Price
$5.74
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GBCS is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
97 /100
Cheap EV/EBITDA 1.27x
P/S 0.54x
P/B 2.21x
Growth
23 /100
Declining Rev. growth 0.69%
FCF growth N/A
Book val. growth N/A
Profitability
22 /100
Weak Net margin 44.83%
Op. margin 12.47%
FCF margin 9.45%
Quality
40 /100
Average ROA 46.37%
Asset turnover 1.03x
ROIC 19.42%
Debt
82 /100
Low Current ratio 1.02x
Int. coverage 5.25x
Net debt/EBITDA -1.00x
Stability
47 /100
Moderate Rev. volatility 9.06%
EPS volatility 66.49%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GBCS
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Krystal Eckhart
Employees
476
Headquarters
Denver
Upcoming events
21 SEP
Earnings
Upcoming earnings report
02 DEC
Earnings
Upcoming earnings report